Literature DB >> 28032710

Anterior and Posterior Instrumentation with Different Debridement and Grafting Procedures for Multi-Level Contiguous Thoracic Spinal Tuberculosis.

Xu Cui1, Li-Tao Li1, Yuan-Zheng Ma1.   

Abstract

OBJECTIVE: To evaluate the clinical outcomes of anterior and posterior instrumentation with different debridement and graft fusion methods for multi-level contiguous thoracic spinal tuberculosis.
METHODS: We retrospectively evaluated 81 patients with multi-level contiguous thoracic spinal tuberculosis who underwent anterior or posterior instrumentation combined with different methods of debridement, decompression, and graft fusion from January 2002 to December 2012. All patients were divided into an anterior instrumentation group and a posterior instrumentation group. In the anterior instrumentation group, there were 39 patients who underwent transthoracic debridement. In the posterior instrumentation group, there were 34 patients who underwent trans-costotransverse decompression and strut grafting with posterior instrumentation, and another 8 patients underwent combined anterior debridement and strut grafting with posterior instrumentation in a single-stage or two-stage procedure. The kyphotic angles were calculated from lateral spinal X-rays using the modified Konstam method. The symptoms and signs of tuberculosis, fusion level, fusion time of the bone graft, average kyphosis angle, average correction, average loss of correction, and clinical complications were recorded. The average follow-up period was 37 months (range, 17-72 months).
RESULTS: The cohort consisted of 47 males and 34 females with an average age of 38 years. The mean durations of the operations were 3.5 ± 0.4 h in the anterior group and 4.0 ± 0.3 h in the posterior group ( P < 0.05). The mean blood loss volumes during surgery were 450 ± 42 and 560 ± 51 mL for the anterior group and the posterior group, respectively ( P < 0.01). The kyphotic deformities were corrected from 32.1° ± 10.3° to 10.2° ± 2.1° in the anterior group and from 33.8° ± 11.7° to 12.6° ± 2.7° in the posterior group ( P < 0.01). The neurologic statuses of the 23 patients with preoperative neurologic deficits improved in each group. Fusion was confirmed radiographically at 5.4 ± 1.2 months (range, 4-12 months) in the anterior group and 5.6 ± 1.4 months (range, 4-13 months) in the posterior group ( P > 0.05). Postoperative relapses were noted in 1 and 3 patients in the anterior and the posterior group, respectively.
CONCLUSION: Posterior instrumentation was more effective than anterior instrumentation in the correction of kyphosis and the maintenance of the correction. However, postoperative sinus formation was more frequent in patients who underwent a single-stage posterior procedure.
© 2016 Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Anterior; Instrumentation; Multi-level; Posterior; Thoracic spinal tuberculosis

Mesh:

Year:  2016        PMID: 28032710      PMCID: PMC6584292          DOI: 10.1111/os.12288

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  9 in total

1.  Analysis of the Therapeutic Effects of Staged Posterior-Anterior Combined Surgery for Cervicothoracic Segmental Tuberculosis with Kyphosis in Pediatric Patients.

Authors:  Haopeng Luan; Qiang Deng; Weibin Sheng; Mardan Mamat; Hailong Guo; Huaqiang Li
Journal:  Int J Gen Med       Date:  2021-08-26

2.  Comparison of clinical and radiological outcomes of local morselized bone grafts and structural iliac bone grafts in the treatment of lumbar tuberculosis with posterior-only surgery.

Authors:  Shuang Xu; Shuai Zhang; Gaoju Wang; Jin Yang; Yueming Song; Qing Wang
Journal:  BMC Surg       Date:  2022-05-14       Impact factor: 2.030

3.  Comparison of anterior or posterior approach in surgical treatment of thoracic and lumbar tuberculosis: a retrospective case-control study.

Authors:  Jincheng Qiu; Yan Peng; Xianjian Qiu; Wenjie Gao; Tongzhou Liang; Yuanxin Zhu; Taiqiu Chen; Wenjun Hu; Bo Gao; Zhihuai Deng; Anjing Liang; Dongsheng Huang
Journal:  BMC Surg       Date:  2022-05-10       Impact factor: 2.030

4.  Comparison of anterior transthoracic debridement and fusion with posterior transpedicular debridement and fusion in the treatment of mid-thoracic spinal tuberculosis in adults.

Authors:  Weiwei Li; Zheng Liu; Xiao Xiao; Zhen Zhang; Xiyang Wang
Journal:  BMC Musculoskelet Disord       Date:  2019-11-27       Impact factor: 2.362

5.  Comparison of three surgical approaches for thoracolumbar junction (T12-L1) tuberculosis: a multicentre, retrospective study.

Authors:  Yanping Zeng; Peng Cheng; Jiulin Tan; Zhilin Li; Yuan Chen; Li Tao Li; Yonghong Zheng; Gaoju Wang; Jianzhong Xu; Zehua Zhang
Journal:  BMC Musculoskelet Disord       Date:  2019-11-09       Impact factor: 2.362

6.  Comparison of anterior, posterior, and anterior combined with posterior surgical treatment of thoracic and lumbar spinal tuberculosis: a systematic review.

Authors:  Zhouliang Bian; Yiding Gui; Fan Feng; Hongxing Shen; Lifeng Lao
Journal:  J Int Med Res       Date:  2019-03-17       Impact factor: 1.671

7.  Comparison of the Clinical Efficacy of 3 Surgical Methods for Treating Spinal Tuberculosis in Children.

Authors:  Weidong Liang; Jian Zhang; Zhouliang Ren; Maierdan Maimaiti; Fulati Mamati; Yakefu Abulizi; Tao Xu; Rui Cao; Jun Sheng; Weibin Sheng
Journal:  Med Sci Monit       Date:  2020-12-25

8.  Comparative Analysis of Long-Term Outcome of Anterior Reconstruction in Thoracic Tuberculosis by Direct Anterior Approach versus Posterior Approach.

Authors:  Sudhir K Srivastava; Manojkumar Gaddikeri; Aditya Raj; Sunil Bhosle; Atif Naseem; Ankit Amin; Harsh Agrawal
Journal:  Asian J Neurosurg       Date:  2021-12-18

9.  Single posterior debridement, interbody fusion, and fixation on patients with continuous multivertebral lumbar spine tuberculosis (CMLSTB).

Authors:  Weihong Long; Liqun Gong; Yaqing Cui; Jie Qi; Dapeng Duan; Weiwei Li
Journal:  BMC Musculoskelet Disord       Date:  2020-09-10       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.